BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17692741)

  • 1. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention.
    Laskey WK; Jenkins C; Selzer F; Marroquin OC; Wilensky RL; Glaser R; Cohen HA; Holmes DR;
    J Am Coll Cardiol; 2007 Aug; 50(7):584-90. PubMed ID: 17692741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
    Worasuwannarak S; Pornratanarangsi S
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention.
    Tan N; Liu Y; Zhou YL; He PC; Yang JQ; Luo JF; Chen JY
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):70-5. PubMed ID: 21990069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serious renal dysfunction after percutaneous coronary interventions can be predicted.
    Brown JR; DeVries JT; Piper WD; Robb JF; Hearne MJ; Ver Lee PM; Kellet MA; Watkins MW; Ryan TJ; Silver MT; Ross CS; MacKenzie TA; O'Connor GT; Malenka DJ;
    Am Heart J; 2008 Feb; 155(2):260-6. PubMed ID: 18215595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the contrast volume or grams of iodine-to-creatinine clearance ratio to predict mortality after percutaneous coronary intervention.
    Tan N; Liu Y; Chen JY; Zhou YL; Li X; Li LW; Yu DQ; Chen ZJ; Liu XQ; Huang SJ
    Am Heart J; 2013 Apr; 165(4):600-8. PubMed ID: 23537978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification.
    Bartholomew BA; Harjai KJ; Dukkipati S; Boura JA; Yerkey MW; Glazier S; Grines CL; O'Neill WW
    Am J Cardiol; 2004 Jun; 93(12):1515-9. PubMed ID: 15194023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.
    Barbieri L; Verdoia M; Marino P; Suryapranata H; De Luca G;
    Eur J Prev Cardiol; 2016 Jun; 23(9):931-7. PubMed ID: 26525064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.
    Capodanno D; Ministeri M; Cumbo S; Dalessandro V; Tamburino C
    Catheter Cardiovasc Interv; 2014 May; 83(6):907-12. PubMed ID: 23934631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult renal impairment is common in patients with peripheral vascular disease and normal serum creatinine.
    Rashid ST; Salman M; Agarwal S; Hamilton G
    Eur J Vasc Endovasc Surg; 2006 Sep; 32(3):294-9. PubMed ID: 16716614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of acute renal failure following percutaneous coronary intervention on long-term mortality.
    Roghi A; Savonitto S; Cavallini C; Arraiz G; Angoli L; Castriota F; Bernardi G; Sansa M; De Servi S; Pitscheider W; Danzi GB; Reimers B; Klugmann S; Zaninotto M; Ardissino D;
    J Cardiovasc Med (Hagerstown); 2008 Apr; 9(4):375-81. PubMed ID: 18334892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
    Nyman U; Björk J; Aspelin P; Marenzi G
    Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xinwei J; Xianghua F; Jing Z; Xinshun G; Ling X; Weize F; Guozhen H; Yunfa J; Weili W; Shiqiang L
    Am J Cardiol; 2009 Aug; 104(4):519-24. PubMed ID: 19660605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creatinine clearance and risk of early mortality in patients undergoing coronary artery bypass grafting.
    Holzmann MJ; Ahnve S; Hammar N; Jörgensen L; Klerdal K; Pehrsson K; Ivert T
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):746-52. PubMed ID: 16153923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe contrast volumes for preventing contrast-induced nephropathy in elderly patients with relatively normal renal function during percutaneous coronary intervention.
    Liu Y; Liu YH; Chen JY; Tan N; Zhou YL; Duan CY; Yu DQ; Xie NJ; Li HL; Chen PY
    Medicine (Baltimore); 2015 Mar; 94(12):e615. PubMed ID: 25816028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease.
    Johnston N; Jernberg T; Lagerqvist B; Wallentin L
    Am Heart J; 2006 Dec; 152(6):1052-8. PubMed ID: 17161052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast Volume-to-Creatinine Clearance Ratio Predicts the Risk of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients With Reduced Ejection Fraction.
    Liu Y; Chen SQ; Duan CY; Tan N; Chen JY; Zhou YL; Chen PY; Huang SJ; Liu XQ
    Angiology; 2015 Aug; 66(7):625-30. PubMed ID: 25158831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system.
    Harjai KJ; Raizada A; Shenoy C; Sattur S; Orshaw P; Yaeger K; Boura J; Aboufares A; Sporn D; Stapleton D
    Am J Cardiol; 2008 Mar; 101(6):812-9. PubMed ID: 18328846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy.
    Liu Y; Chen JY; Tan N; Zhou YL; Yu DQ; Chen ZJ; He YT; Liu YH; Luo JF; Huang WH; Li G; He PC; Yang JQ; Xie NJ; Liu XQ; Yang DH; Huang SJ; Piao-Ye ; Li HL; Ran P; Duan CY; Chen PY
    Circ Cardiovasc Interv; 2015 Jun; 8(6):. PubMed ID: 26041500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction.
    Giraldez RR; Sabatine MS; Morrow DA; Mohanavelu S; McCabe CH; Antman EM; Braunwald E
    Am Heart J; 2009 Mar; 157(3):517-24. PubMed ID: 19249423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.